Therapeutics and COVID-19: living guideline, WHO

Recommendations: The panel made a conditional recommendation against the use of remdesivir in hospitalized patients with COVID-19, regardless of disease severity. This guidance adds to recommendations published in the previous version: a strong recommendation for systemic corticosteroids in patients with severe and critical COVID-19, and a conditional recommendation against systemic corticosteroids in patients with non-severe COVID-19.
Source: Current Awareness Service for Health (CASH) - Category: Consumer Health News Source Type: news